Tumour necrosis factor alpha (TNF ) has been implicated in the pathophysiology of neurodegenerative and neuropsychiatric disease, with research highlighting a role for TNF in hippocampal and striatal regulation. TNF signals are primarily transduced by TNF receptors 1 and 2 (TNFR1 and TNFR2), encoded by TNFRSF1A and TNFRSF1B, which exert opposing effects on cell survival (TNFR1, neurodegenerative; TNFR2, neuroprotective). We therefore sought to explore the respective roles of TNFR1 and TNFR2 in the regulation of hippocampal and striatal morphology in an imaging genetics study. Voxel-based morphometry was used to analyse the associations between TNFRSF1A (rs4149576 and rs4149577) and TNFRSF1B (rs1061624) genotypes and grey matter structure. The final samples comprised a total of 505 subjects (mean age = 33.29, SD = 11.55 years; 285 females and 220 males) for morphometric analyses of rs1061624 and rs4149576, and 493 subjects for rs4149577 (mean age = 33.20, SD = 11.56 years; 281 females and 212 males). Analyses of TNFRSF1A single nucleotide polymorphisms (SNPs) rs4149576 and rs4149577 showed highly significant genotypic associations with striatal volume but not the hippocampus. Specifically, for rs4149576, G homozygotes were associated with reduced caudate nucleus volumes relative to A homozygotes and heterozygotes, whereas for rs4149577, reduced caudate volumes were observed in C homozygotes relative to T homozygotes and heterozygotes. Analysis of the TNFRSF1B SNP rs1061624 yielded a significant association with hippocampal but not with striatal volume, whereby G homozygotes were associated with increased volumes relative to A homozygotes and heterozygotes. Our findings indicate a role for TNFR1 in regulating striatal but not hippocampal morphology, as well as a complementary role for TNFR2 in hippocampal but not in striatal morphology.
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Neuroinflammation is widely considered to be a common mechanism underlying degeneration across a multitude of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease (PD), Huntington's disease, amyotrophic lateral sclerosis and the tauopathies (Frank-Cannon et al. 2009 ). Likewise, neuroinflammation has also been implicated in the pathophysiology of neuropsychiatric disease and related endophenotypes including schizophrenia, affective disorders and cognitive function (Dowlati et al. 2010; Fillman et al. 2013; Lamers et al. 2013; McAfoose & Baune 2009 ). For example, the hippocampal atrophy often observed in major depressive disorder cases (Stratmann et al. 2014) has been attributed, at least in part, to neuroinflammatory mechanisms (Savitz et al. 2015) .
The proinflammatory cytokine tumour necrosis factor alpha (TNF ) has received a great deal of attention within the context of neurodegenerative and psychiatric disease (Montgomery & Bowers 2012) . Tumour necrosis factor alpha is produced in transmembrane (34 kDa) and soluble (17 kDa) forms, both of which are expressed widely across peripheral and central immune cells whilst also being constitutively expressed by neurons and astrocytes (Cabal-Hierro & Lazo 2012) . Research has shown that TNF is a pleiotropic protein capable of exerting either neuroprotective or neurodegenerative effects under distinct conditions and across different brain regions (Sriram & O'Callaghan 2007) . Indeed, the striatum and hippocampus have emerged as prominent brain regions showing the pleiotropic nature of TNF , with evidence pointing towards a neurotoxic role in the striatum (Barnum et al. 2014; McCoy et al. 2006 ) and a neuroprotective role in the hippocampus (Carlson et al. 1998; Liu et al. 1999 ).
The precise role TNF might play within and across neurodegenerative and neuropsychiatric disease is therefore not straightforward. Although clinical evidence has shown that TNF levels are vastly perturbed in cerebrospinal fluid and post-mortem brain tissue from neurodegenerative disease cases relative to controls (Boka et al. 1994; Mogi et al. 1995; Pickering & O'Connor 2007; Tarkowski et al. 2003) , these changes could represent either disease pathophysiology or compensatory, protective mechanisms. Thus, in order to facilitate in our understanding of the precise role TNF plays in human pathological brain conditions, a more comprehensive understanding of the effects of TNF on brain structure and function under normal conditions in vivo is required. In a recent imaging genetics study looking at the relationship between TNF gene variation and brain structure in a large sample of healthy adults (n = 303), highly significant associations between hippocampal volume and two independent TNF single nucleotide polymorphisms (SNPs) (rs1800629 and rs361525) were observed in both region-of-interest (ROI) and whole-brain analyses (Baune et al. 2012) .
A vital next step in elucidating this apparent relationship between TNF and hippocampal volume is to begin to trace the relevant downstream signalling pathways. TNF signals are primarily transduced by two distinct receptors referred to as TNF receptors 1 and 2 (TNFR1 and TNFR2), which are encoded by the genes TNFRSF1A and TNFRSF1B, respectively (Cabal-Hierro & Lazo 2012) . Numerous studies have shown that TNF signalling through these receptors exerts distinct physiological and behavioural effects in mice (Baune et al. 2008; Cabal-Hierro & Lazo 2012; Camara et al. 2013) , with early research indicating that TNFR1 is responsible for promoting cell death whereas TNFR2 counters this by activating anti-apoptotic signalling cascades (Bernardino et al. 2005; Fontaine et al. 2002) . More recently, however, evidence suggests that TNFR1 may in fact be capable of exerting dual functionality by also providing anti-apoptotic signals in some contexts (Al-Lamki & Mayadas 2014) . Indeed, a study investigating viral-induced encephalitis across Tnf −/− , Tnfr1 −/− and Tnfr2 −/− mice has shown that TNF signalling through TNFR1 appears to be reparative in the hippocampus (Rodriguez et al. 2009a) . However, in the same study, it was TNFR2, not TNFR1, that was found to exert a reparative effect in the striatum (Rodriguez et al. 2009a) , indicating that the downstream effects of TNFR1 and TNFR2 signalling are in fact brain region-specific.
In this study, we sought to extend upon current knowledge of TNF -mediated effects on brain volume by shifting focus, for the first time, to the TNF receptors TNFR1 and TNFR2 in an imaging genetics study investigating brain morphology in a large sample of healthy adults (n = 520). Specifically, we conducted ROI analyses focusing on the hippocampus and striatum using structural magnetic resonance imaging (MRI) data, which we also supplemented with whole-brain analyses. Based on previous research showing the distinct effects of (1) TNF signalling in the striatum relative to the hippocampus (Barnum et al. 2014; Carlson et al. 1998; Liu et al. 1999; McCoy et al. 2006) and (2) TNFR1 (primarily promotion of cell death) and TNFR2 (promotion of anti-apoptotic signals) signalling downstream of TNF binding (Bernardino et al. 2005; Fontaine et al. 2002) , we expect to show divergent or opposing effects of TNFR1 and TNFR2 polymorphisms on hippocampal and striatal morphology.
Materials and methods

Participants
The complete data set comprised 520 healthy volunteers. Data were collected in the context of a large ongoing study (Münster Neuroimaging Cohort) investigating the neurobiology of emotional processes. All subjects underwent structural measurements using MRI. For all analyses, nine subjects were excluded because of anatomical abnormalities, as well as six additional subjects owing to overall genotyping failures. Furthermore, 12 additional subjects had to be excluded for rs4149677 analyses because of SNP genotyping failures. This left a total of 505 subjects (mean age = 33.29, SD = 11.55 years; 285 females and 220 males) for morphometric analyses of rs1061624 and rs4149576, and 493 subjects (mean age = 33.20, SD = 11.56 years; 281 females and 212 males) for rs4149577. Participants were recruited using public notices and newspaper announcements. All subjects were free from a history of psychiatric illness according to diagnostic and statistical manual of mental disorders (DSM)-IV criteria (American Psychiatric Association 1994) as diagnosed by experienced psychologists using the structured clinical interview for DSM (SCID) interview (Wittchen et al. 1997) . There was no evidence of any neurological conditions, participants were not taking psychotropic medication, had normal or corrected-to-normal vision and had adequate knowledge of German and cognitive abilities [verbal IQ > 80; multiple-choice vocabulary intelligence test MWT-B (Lehrl 2005) ]. Trait anxiety was assessed by the State-Trait Anxiety Inventory -Trait Version (Spielberger et al. 1970) . The Beck Depression Inventory (Beck & Steer 1987; Hautzinger et al. 1994 ) was used to assess the presence of depressive symptoms.
Subjects were screened for imaging safety concerns and written informed consent was obtained. The Medical Faculty ethics committee at the University of Münster approved all experimental procedures. For detailed sample characteristics, see Table 1 .
SNP selection
The TNFR1 and TNFR2 are encoded by TNFRSF1A (chromosome 12p13.31) and TNFRSF1B (chromosome 1p36.22), respectively. We based our SNP selection on the following criteria: (1) SNPs should have been validated by both the HapMap project and the 1000 genomes project in Caucasian populations; (2) SNPs should have a high minor allele frequency (MAF) (i.e. >0.20) in order to maximize power and (3) SNPs should have previously been significantly associated with complex human phenotypes in peer-reviewed published articles. We first considered non-synonymous SNPs within TNFRSF1A and TNFRSF1B because of the increased likelihood that they might exert functional effects, although they did not fulfil the above-described criteria sufficiently. In TNFRSF1A we selected two SNPs, rs4149576 and rs4149577, which are located in close proximity to each other within intron 1. According to the 1000 genomes project (pilot 1), these SNPs have an MAF of 0.492 and 0.433 in Caucasians (i.e. northern europeans from utah (CEU) population), respectively, and are in high linkage disequilibrium (LD) with r 2 = 0.740 (D ′ = 1). Both SNPs have previously been implicated in numerous complex human diseases including sporadic breast cancer (Xu et al. 2014) , inflammatory demyelinating disease (Park et al. 2013 ) and ankylosing spondylitis (Davidson et al. 2011) . In TNFRSF1B, we selected a single SNP, rs1061624, which resides in the 3 ′ untranslated region (UTR) and has an MAF of 0.417 in the CEU population according to the 1000 genomes project (pilot 1). Numerous previous studies indicate that this SNP is involved in inflammatory bowel disease (Ferguson et al. 2009 ), tuberculosis (Mokrousov et al. 2011) , sporadic breast cancer (Xu et al. 2014 ) and colorectal cancer (Yu et al. 2014) . It is worth noting that rs4149577 (TNFRSF1A) and rs1061624 (TNFRSF1B) are also haplotype-tagging SNPs.
SNP genotyping
Genomic DNA was extracted from whole blood samples using the QIAamp DNA Blood Mini Kit (QIAGEN, Melbourne, Victoria Australia). Genotyping of the selected TNFRSF1A SNPs (rs4149576 and 
Voxel-based morphometry (VBM) acquisition and statistical analyses
T1-weighted high-resolution anatomical images were acquired with a 3D fast gradient echo sequence ('Turbo Field Echo'), repetition time (TR) = 7.4 milliseconds, echo time (TE) = 3.4 milliseconds, flip angle (FA) = 9 ∘ , two signal averages, inversion prepulse every 814.5 milliseconds, acquired over a field of view of 256 foot-to-head direction (FH) × 204 anterior-to-posterior (AP) × 160 right-to-left direction (RL) mm 3 , phase encoding in AP and RL direction, reconstructed to cubic voxels of 0.5 × 0.5 × 0.5 mm 3 . As described in our previous work (Dannlowski et al. 2014a (Dannlowski et al. ,2014b Redlich et al. 2016; Stacey et al. 2014) , the VBM8-TOOLBOX (http://www.neuro.uni-jena .de/vbm) was used for preprocessing the structural images with default parameters. Images were bias-corrected, tissue classified and normalized to Montreal Neurological Institute-space using linear (12-parameter affine) and non-linear transformations, within a unified model (Ashburner & Friston 2005) including high-dimensional DARTEL-normalization. Grey matter segments were modulated only by the non-linear components in order to preserve actual gray matter (GM) values locally (modulated GM volumes). The MRIs were read for anatomical abnormalities and technical artefacts by a senior radiologist. Common exclusion criteria were: (1) structural defects; (2) tumorous abnormalities; (3) hydrocephalus and neurological abnormalities including stroke, epilepsy, multiple sclerosis, PD or dementia, head trauma or unconsciousness and (4) the usual MRI contraindications. The segmented grey matter images were checked for homogeneity using the VBM8-TOOLBOX.
Overall, our quality check yielded nine subjects showing anatomical abnormalities or strong artefacts, which were therefore excluded from analysis. The remaining 511 images were clear of such problems. The modulated grey matter images were smoothed with a Gaussian kernel of 8-mm full width at half maximum (FWHW).
To investigate the effects of rs1061624, rs4149576 and rs4149577, three separate one-way analyses of variance (ANOVAs) were conducted using genotype group as between-subjects factor. Age and sex were added to the models as nuisance regressors. Owing to an upgrade of the scanner gradient system in 2008 ('Master' Gradient System to 'Quasar Dual' Gradient System), the scanner upgrade was additionally modelled as regressor of no interest, although the MRI sequence remained identical before and after the gradient system upgrade.
For each SNP, three ROI analyses were performed restricting our analyses to the bilateral hippocampus including the parahippocampal gyrus (1), the bilateral caudate nucleus (2) and the bilateral putamen (3) -as defined by the anatomical automatic labelling (AAL)-atlas (Tzourio-Mazoyer et al. 2002) , implemented in the Wake Forest University (WFU) pickatlas (Maldjian et al. 2003) .
To control for multiple statistical testing, a cluster-level false-positive detection rate of P < 0.006 (P = 0.05/9, resulting from three ROI analyses for three SNPs) was applied, using a voxel-level threshold of P < 0.05 with a cluster extent (k) empirically determined by Monte-Carlo simulations (n = 1000 iterations). This was performed by means of the AlphaSim (Forman et al. 1995) procedure, as implemented in the REST TOOLBOX; V1.8 (http://restfmri.net/ forum/index.php), as reported in our previous publications Redlich et al. 2015a Redlich et al. ,2015b Redlich et al. ,2015c . This yielded an empirically determined cluster extent of k = 194 voxel for the hippocampus, k = 133 for the bilateral putamen and k = 75 for the caudate nucleus.
Additionally, an exploratory whole-brain analysis for each SNP was conducted with a voxel-level threshold of P < 0.001 and an empirically determined cluster extent of k = 449 voxels. The anatomical labelling was performed by means of the AAL-TOOLBOX (Tzourio-Mazoyer et al. 2002) , and the Brodmann areas were identified with the TALAIRACH DAEMON ATLAS (http://www.talairach.org).
Results
SNP genotyping results
Overall, using iPLEX assays on the MassARRAY platform, we observed 6 genotyping failures for SNPs rs1061624 and rs4149576, along with 18 genotyping failures for rs4149577. This resulted in overall genotyping completion rates of 98.8%, 98.8% and 96.5%, respectively. Genotyping therefore yielded 100 AAs, 254 AGs and 151 GGs with an MAF of 0.45 for rs1061624; 92 AAs, 263 AGs and 150 GGs with an MAF of 0.44 for rs4149576 and 108 CCs, 231 CTs and 154 TTs with an MAF of 0.45 for rs4149577. These genotype and allele frequencies are highly comparable to those observed in the CEU population by the 1000 genomes project (pilot 1) (see Materials and methods), although it is worth noting that the LD between rs4149576 and rs4149577 observed in our sample was slightly lower (i.e. r 2 = 0.657, D ′ = 0.98) than that observed in the above 1000 genomes population (i.e. r 2 = 0.740, D ′ = 1).
ROI voxel-based morphometry
Analyses of the TNFRSF1A SNPs, rs4149576 and rs4149577, showed highly similar results. While there were no significant effects within the hippocampus, there were significant main effects in the caudate nucleus for rs4149576 (x = 20, y = 16, z = 15, Z = 3.68, P = 0.0001, k = 661) as well as rs4149577 (x = 18, y = 14, z = 13, Z = 3.66, P = 0.0001, k = 612; x = −18, y = 17, z = 15, Z = 2.73, P = 0.003, k = 135). Post hoc t-tests for rs4149577 showed a smaller caudate nucleus volume in C homozygotes compared with T homozygotes (x = 18, y = 12, z = 21, Z = 3.98, P = 0.00003, k = 1040; x = −18, y = 17, z = 15, Z = 3.35, P = 0.00006, k = 539) and slightly weaker compared with CT heterozygotes (x = 18, y = 14, z = 21, Z = 3.67, P = 0.0001, k = 748; x = −18 y = 11, z = 21, Z = 2.85, P = 0.0001, k = 186). When splitting the samples according to sex, these results were significant for both males (P = 0.002) and females (P = 0.01), indicating this was not a sex-specific effect. In rs4149576, the results were driven by a smaller caudate nucleus volume in G homozygotes compared with A homozygotes (x = 20, y = 18, z = 13, Z = 4.20, P = 0.00001, k = 986; x = −16, y = 17, z = 13, Z = 3.19, P = 0.00002, k = 485) and AG heterozygotes (x = 18, y = 15, z = 19, Z = 3.00, P = 0.001, k = 633; x = −18, y = 18, z = 6, Z = 2.58, P = 0.005, k = 140) (Fig. 1a) . Likewise, this effect remained significant in both males (P = 0.003) and females (P < 0.001) after stratification by sex.
Additionally, there was a main effect of the putamen (x = −33, y = −15, z = −3, Z = 3.40, P = 0.0003, k = 246) for rs4149576, but not for rs4149577, resulting from a higher putamen volume in A homozygotes compared with both G homozygotes (x = −33, y = −16, z = −3, Z = 3.71, P = 0.0001, k = 191; x = 24, y = 10, z = 12, Z = 3.67, P = 0.0001, k = 532) as well as AG heterozygotes (x = −32, y = −15, z = −2, Z = 3.73, P = 0.00009, k = 515; x = 28, y = −3, z = 3, Z = 3.26, P = 0.001, k = 423).
The analyses of the TNFRSF1B SNP rs1061624 yielded a significant main effect of the hippocampus (right: x = 20, y = −10, z = −30, Z = 4.18, P = 0.00001, cluster size k = 373; left: x = −18, y = −40, z = 7, Z = 3.07, P = 0.001, k = 247) resulting from increased hippocampal volume in G homozygotes compared with A homozygotes (x = 15, y = −9, z = −23, Z = 3.03, P = 0.001, k = 270) and AG heterozygotes (x = 20, y = −10, z = −30, Z = 4.65, P < 0.00001, k = 1339) (Fig. 1b) , which remained highly significant in both males and females (both P < 0.001) after stratification by sex. There were no significant differences for either the putamen or the caudate nucleus.
Whole-brain voxel-based morphometry
For rs4149576 (TNFRSF1A), the whole-brain analysis also yielded a single cluster comprising solely the caudate nucleus (x = 20, y = 18, z = 13, Z = 4.24, P = 0.00001, k = 837) in the same direction as already described above in the ROI analyses. For rs4149577 (TNFRSF1A), the cluster containing the caudate nucleus did not survive the entire brain correction, although whole-brain analysis did yield a cluster within the cerebellum (x = 14, y = −76, z = −33, Z = 3.93, P = 0.00004, k = 1077), whereby increased cerebellum volume was observed in heterozygotes relative to C homozygotes (x = 4, y = −78, z = −29, Z = 4.26, P < 0.00001, k = 602) and T homozygotes (x = 21, y = −81, z = −21, Z = 4.29, P < 0.00001, k = 2226). No significant whole-brain clusters were observed for rs1061624 (TNFRSF1B).
Discussion
To summarize the main findings, our analyses showed significant associations between genetic variants of TNFRSF1A (rs4149576 and rs4149577) and striatal but not hippocampal morphology, whereas rs1061624 in TNFRSF1B was associated with hippocampal volume only. Both TNFRSF1A SNPs were associated with caudate nucleus morphological changes, while rs4149576 was also associated with morphological changes to the putamen. Specifically, individuals homozygous for the C allele of rs4149577 exhibited significantly reduced caudate nucleus volumes relative to T homozygotes and heterozygotes, whilst individuals homozygous for the G allele of rs4149576 exhibited reduced caudate and putamen morphology relative to A homozygotes and heterozygotes. Conversely for the TNFRSF1B SNP, rs1061624, analyses showed a significant association with hippocampal but not with striatal morphology, whereby the G homozygotes were associated with increased hippocampal volume relative to the A homozygotes and heterozygotes.
Thus, our findings indicate that TNFR1 and TNFR2 exert distinct effects on striatal and hippocampal morphologies, which are in accordance with our hypothesis. As outlined in the section Introduction, previous research (performed primarily in animal models) has already shown that TNF exerts distinct effects in the striatum (promotion of cell death) and hippocampus (neuroprotective) (Barnum et al. 2014; Carlson et al. 1998; Liu et al. 1999; McCoy et al. 2006) . Our findings suggest that these region-specific effects may be due, at least in part, to differential TNF binding and/or activity of TNFR1 and TNFR2 in the striatum and hippocampus. Indeed, a very recent study investigating the relative effects of TNFR1 and TNFR2 in the striatum and hippocampus using a viral-induced mouse model of encephalitis also provides convincing support for a region-specific and differential effect on brain morphology (Rodriguez et al. 2009a ). However, it should be acknowledged here that findings from our study and the study by Rodriguez et al. (2009a) are discordant in terms of the direction of the TNFR1/TNFR2 region specificity observed. Indeed, in our study, we found that striatal morphology was affected by TNFRSF1A polymorphisms, whereas Rodriguez et al. (2009a) observed TNFR2-dependent reparative effects in the striatum. Conversely, in the hippocampus, we found an association between the TNFRSF1B polymorphism and altered morphology, whereas Rodriguez et al. (2009a) found that it was TNFR1, but not TNFR2, that was responsible for the reparative effects observed in the hippocampus.
Of course, the extent to which findings from a viral-induced mouse model of encephalitis can (and should) be translated to healthy adult humans, and vice versa, is unclear. Indeed, considering the apparent region-specific effects of TNF , TNFR1 and TNFR2, the overall functioning of this system can reasonably be expected to be different not only across species but also between healthy and pathophysiological conditions. We therefore urge replication of our imaging genetics findings in independent healthy human adult samples as well as clinical samples in order to validate and further elucidate/explore our findings. In addition, we also urge further work using post-mortem human brain tissue (as opposed to animal models) in order to directly complement our neuroimaging findings. For example, knowledge of the relative mRNA expression levels of TNFRSF1A and TNFRSF1B in human striatal and hippocampal tissue may serve to further elucidate the region specificity observed in our study.
Shifting focus to the interpretation of individual receptor findings, in our study, both of the selected TNFRSF1A polymorphisms (rs4149576 and rs4149577) were found to be significantly associated with striatal (but not hippocampal) morphology. For rs4149576, reduced caudate and putamen morphologies were associated with G homozygotes relative to A homozygotes and heterozygotes, whereas for rs4149577, reduced caudate (but not putamen) morphology was associated with C homozygotes relative to T homozygotes and heterozygotes. Based on previous research indicating that (1) TNF signalling in the striatum is neurodegenerative (Barnum et al. 2014; McCoy et al. 2006) and (2) signalling through TNFR1 generally promotes cell death (Bernardino et al. 2005; Fontaine et al. 2002) , we propose that the above-described relative reductions in striatal morphology associated with G homozygotes (rs4149576) and C homozygotes (rs4149577) are mediated by an increase in neurodegenerative signalling through TNFR1. However, as mentioned in the section Introduction, TNFR1 is also capable of promoting anti-apoptotic mechanisms in some contexts (Rodriguez et al. 2009a) , and so we cannot rule out the possibility that altered striatal volume might instead be mediated by altered anti-apoptotic signalling through TNFR1.
The effects of rs4149576 and/or rs4149577 on TNFRSF1A gene function (if there are any) are not yet known. Both SNPs reside close together within intron 1 of TNFRSF1A, and according to CEU 1000 genomes (pilot 1) data they are in high LD with each other (r 2 = 0.74, D ′ = 1) suggesting that they might overlap in functional terms (Johnson et al. 2008) . Given their intronic positioning and considering that they are not in LD with any coding SNPs, it is most likely that rs4149576 and/or rs4149577 influence either transcription or splicing of TNFRSF1A. Further research using post-mortem human brain tissue to confirm whether these SNPs influence TNFRSF1A gene function, particularly where striatal tissue is available, is now required to facilitate in the elucidation of our striatal imaging findings. Indeed, by linking rs4149576/rs4149577 genotypes or alleles with either increased or decreased TNFRSF1A gene expression levels, we would be able to determine the relationship between TNFRSF1A expression levels and striatal morphology. This may enable us to infer whether TNFR1 protein activity in the healthy adult striatum does in fact promote neurodegenerative mechanisms, as expected, or whether anti-apoptotic mechanisms are activated.
Interestingly, our TNFRSF1A findings also suggest an additional, and novel, layer of functional specificity within the striatum, whereby both SNPs (rs4149576 and rs4149577) were associated with caudate nucleus morphology, whilst only rs4149576 was also associated with putamen volume. This indicates that the two TNFRSF1A SNPs, despite their high LD, may in fact confer distinct striatal subregion-specific effects on TNFRSF1A expression or splicing, which might warrant further study. In addition, our TNFRSF1A findings also indicate a morphological effect of TNFRSF1A outside of the striatum, whereby whole-brain analyses showed a significant association between rs4149577 genotype and a cluster in the cerebellum. Increased cerebellar volume was observed in rs4149577 heterozygotes relative to both T and C homozygotes, which is a difficult pattern to justify biologically. Nevertheless, TNF has previously been implicated in murine cerebellar degeneration in response to both glutamatergic excitotoxicity (Bliss et al. 2011) and hypoxia (Kaur et al. 2014) , as well as in a mouse model of Niemann-Pick type C disease (Wu et al. 2005) .
With regards to TNFR2, in our study, the TNFRSF1B SNP rs1061624 was found to be significantly associated with hippocampal (but not striatal) morphology, whereby G homozygotes exhibited increased morphology relative to A homozygotes and heterozygotes. Based on previous research indicating that (1) TNF signalling in the hippocampus is neuroprotective (Carlson et al. 1998; Liu et al. 1999) and (2) signalling through TNFR2 activates anti-apoptotic mechanisms (Bernardino et al. 2005; Fontaine et al. 2002) , we propose that the increased morphology observed in G homozygotes is caused by a relative increase in anti-apoptotic signalling through TNFR2, which would likely result in reduced cell death relative to A homozygotes and heterozygotes. Although the effects of rs1061624 on TNFRSF1B gene function are not yet known, this SNP resides within the 3 ′ UTR of TNFRSF1B, which is considered to be a major target for microRNA (miRNA) molecules that promote the degradation of mRNA, thereby reducing protein levels by averting translation.
We therefore propose that rs1061624 may alter the binding potential of a particular miRNA molecule, resulting in genotype-specific alterations in TNFRSF1B mRNA and protein abundance levels. To explore this in silico, we used the SNP function prediction tool available at http://snpinfo .niehs.nih.gov/snpinfo/snpfunc.php (Xu & Taylor 2009) , which predicts that the G allele of rs1061624 abolishes binding sites for two distinct miRNA molecules, Hsa-miR-639 and Hsa-miR-720. This suggests that TNFRSF1B mRNA molecules expressing the G allele may be less susceptible to mRNA degradation than those expressing the A allele, resulting in increased TNFR2 protein abundance associated with the G allele. Follow-up gene expression work is required to validate this prediction, although if the above-described miRNA model is correct, then this indicates that the increased hippocampal volumes observed in individuals homozygous for the G allele may be because of increased TNFR2 protein levels. Interestingly, this putative increase in TNFR2 protein levels is in keeping with our earlier proposal that the increased hippocampal volume observed in G homozygotes may be because of an increase in anti-apoptotic signalling through TNFR2.
It is worth drawing attention here to a large mega-analysis of genome-wide association study (GWAS) human hippocampal morphology data performed recently in >7000 individuals. However, this study did not highlight TNF, TNFRSF1A, TNFRSF1B or indeed any other immune/inflammatory component encoding genes in the regulation of human hippocampal morphology. This is arguably not surprising given the extremely stringent threshold for genome-wide significance, which in this case only yielded one statistically significant SNP, rs7294919, that was found to be a significant cis expression quantitative trait locus for the TESC gene (Stein et al. 2012) . Thus, this highlights the importance of continued hypothesis-based genetic association studies in order to complement large-scale GWAS and therefore facilitates in the identification of additional regulators of hippocampal morphology. We therefore urge replication of our findings in independent samples in order to assess both reliability and generalizability.
Nevertheless, we acknowledge that valid SNP selection in candidate-based studies represents both a non-trivial issue and a limitation of this study. We based our SNP selection on previous studies implicating TNFRSF1A and TNFRSF1B SNPs in complex human phenotypes, with the underlying assumption being that these SNPs (or local tagged variants) must exert some functional effect. Although we have made an effort above to determine in silico what the functional effects of our selected SNPs might be, this requires extensive follow-up functional research. An alternative strategy for SNP selection would have been a haplotype-tagging approach to identify SNPs that best represent the variation in and around both TNFRSF1A and TNFRSF1B, preferably genotyping a range of SNPs that provide coverage across the gene. However, we opted against this strategy because of concerns over the significant correction for multiple testing burden (see section SNP selection). In future work, time-and cost-allowing, we suggest candidate gene association studies be preceded by in-depth functional validation work, ideally using relevant tissue samples, to actively distinguish functional from non-functional genetic variation.
On the neuroimaging side, future studies may benefit by investigating surface area and cortical thickness measurements separately since these measures have been suggested to be more sensitive than VBM, particularly for imaging genetic studies (Hutton et al. 2009; Winkler et al. 2010) . Furthermore, follow-up analyses using functional MRI data to explore cognition and other relevant phenotypes would likely prove useful to validate and extend our knowledge concerning genotype-VBM associatons. Finally, although we found no sex-specific effects of TNFRSF1A/ TNFRSF1B genotype on striatal or hippocampal morphology in this study, other potential interacting factors warrant investigation in future studies. Given the neurodegenerative/regenerative properties of inflammatory modules, perhaps the most obvious example would be advanced age. Thus, replication in an elderly population sample could yield very important findings.
In terms of possible clinical applicability of our findings, the hippocampus and striatum constitute two of the major regions affected in neurodegenerative and neuropsychiatric diseases (Fjell et al. 2014; Kempermann et al. 2008; Sriram & O'Callaghan 2007) . Thus, although our findings have elucidated the influence of TNFR1 and TNFR2 in healthy controls only, they may have important implications for clinical neuroscience. Not only have we confirmed that the TNF system might represent a viable target for therapeutic intervention, but also highlighted the fact that targeting of this system should be tailored, and specific, depending on the brain region in question. Indeed, attempts to take advantage of the neuroprotective role of TNF in the hippocampus by enhancing TNFR2 signalling could have adverse consequences in the striatum. This type of seesaw effect highlights the need for ways to therapeutically target specific brain regions or even cell types, which is a resolution that is difficult to achieve. Lentiviral-mediated gene delivery using region-or cell-specific promoters may provide a promising means by which this could be achieved, although the blood-brain barrier continues to be a significant hurdle that must be climbed in order for this type of approach to be viable (Cederfjäll et al. 2012) .
Conclusions
In conclusion, to our knowledge, this is the first candidate-driven imaging genetics study to investigate the influence of SNPs in TNFRSF1A (TNFR1) and TNFRSF1B (TNFR2) on brain morphology in a large sample of healthy controls (n = 520). Our findings indicate that the apparently divergent roles for TNF in striatal (neurodegenerative) and hippocampal (neuroprotective) regulation are because of differential region-specific TNF signalling through its primary receptors TNFR1 and TNFR2. Indeed, we have uncovered a role for TNFR1 in specifically regulating striatal but not hippocampal morphology, as well as a complementary role for TNFR2 in hippocampal but not in striatal morphology. We now urge replication of our findings in independent healthy adult samples as well as in various clinical samples in order to further explore their potential clinical applicability.
